News Releases

News Releases

August 04, 2017
Aug
04
2017

TEL AVIV, Israel , Aug. 04, 2017 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the second quarter ended June 30, 2017 . Second Quarter 2017 Financial Results and Cash Position R&D...

Continue reading

August 04, 2017
Aug
04
2017

TEL AVIV, Israel , Aug. 04, 2017 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the second quarter ended June 30, 2017 . Second Quarter 2017 Financial Results and Cash Position R&D...

Continue reading

June 05, 2017
Jun
05
2017

JSB-Partners Engaged to Lead the Effort Company Receives Regulatory Clearance to Initiate a Phase 2b trial of Trehalose in OPMD patients TEL AVIV, Israel , June 05, 2017 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today...

Continue reading

May 26, 2017
May
26
2017

TEL AVIV, Israel , May 26, 2017 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the first quarter ended March 31, 2017 . First Quarter 2017 Financial Results and Cash Position R&D...

Continue reading